US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 111.480
  • -1.620-1.43%
Close Nov 1 16:00 ET
  • 111.480
  • 0.0000.00%
Post 20:02 ET
26.51BMarket Cap-48532P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-62.91%1.63B
53.16%-317.3M
-60.44%5.37B
2.62%850.9M
-83.03%811.2M
11.93%4.39B
-116.73%-677.4M
1,426.06%13.58B
515.64%829.2M
218.42%4.78B
Net income from continuing operations
-95.49%-805.8M
-146.88%-331.8M
-90.84%1.19B
-79.10%663.2M
-90.70%227.4M
-117.77%-412.2M
-85.90%707.7M
-13.91%12.95B
-32.70%3.17B
-47.63%2.44B
Operating gains losses
96.92%-8.4M
-120.85%-27M
-130.82%-118.7M
-70.02%157.3M
-118.05%-20.6M
-5.82%-272.9M
2,983.33%129.5M
218.27%385.1M
1,047.11%524.7M
167.40%114.1M
Depreciation and amortization
56.43%49.9M
21.97%38.3M
48.74%183.4M
171.72%78.8M
23.28%41.3M
-3.92%31.9M
13.77%31.4M
63.96%123.3M
11.54%29M
69.19%33.5M
Other non cash items
10.60%-140M
78.70%-172.5M
-328.16%-1.28B
-89.70%-158.4M
-2,854.90%-150.7M
-7,557.14%-156.6M
-281.26%-809.8M
-249.62%-297.9M
-1,310.14%-83.5M
-108.32%-5.1M
Change In working capital
-49.72%2.37B
366.46%222.5M
23.38%5.57B
45.18%-803.8M
-77.83%639.4M
80.73%4.7B
-90.41%47.7M
142.11%4.52B
-0.45%-1.47B
193.07%2.88B
-Change in receivables
-61.33%1.6B
-44.26%498.2M
22.98%5.37B
-97.06%-1.27B
-71.89%631.2M
30.31%4.14B
321.51%893.8M
137.01%4.37B
62.24%-646.8M
167.15%2.25B
-Change in inventory
121.37%5.3M
-20.65%12.3M
30.21%81.9M
140.06%58M
-54.46%33.2M
-127.07%-24.8M
-64.12%15.5M
114.35%62.9M
-32.72%-144.8M
182.84%72.9M
-Change in payables and accrued expense
28.36%760.8M
66.57%-288M
38.74%118.9M
161.19%412.8M
-104.42%-25M
189.38%592.7M
-200.48%-861.6M
-94.35%85.7M
-286.25%-674.6M
69.99%565.9M
Cash from discontinued investing activities
Operating cash flow
-62.91%1.63B
53.16%-317.3M
-60.44%5.37B
2.62%850.9M
-83.03%811.2M
11.93%4.39B
-116.73%-677.4M
1,426.06%13.58B
515.64%829.2M
218.42%4.78B
Investing cash flow
Cash flow from continuing investing activities
89.47%-241.4M
-213.35%-2.3B
-19,601.13%-6.95B
-1,573.98%-2.7B
-1,379.23%-1.23B
-2,823.21%-2.29B
-355.88%-735.4M
93.76%-35.3M
-61.16%-161M
79.59%-83.3M
Net PPE purchase and sale
-31.55%-88.4M
-29.42%-58.5M
23.89%-250.1M
38.64%-83.7M
30.32%-54M
4.82%-67.2M
-2.49%-45.2M
-164.79%-328.6M
-264.71%-136.4M
-92.31%-77.5M
Net intangibles purchase and sale
78.23%-52.7M
-716.67%-78.4M
-1,235.48%-455.4M
-1,248.10%-106.5M
-1,968.09%-97.2M
-4,943.75%-242.1M
42.51%-9.6M
-28.68%-34.1M
43.57%-7.9M
-487.50%-4.7M
Net business purchase and sale
----
----
---336.9M
--0
---336.9M
----
----
--0
--0
--0
Net investment purchase and sale
94.94%-100.3M
-218.47%-2.17B
-1,905.77%-5.91B
-14,899.40%-2.5B
-67,545.45%-744.1M
-65,983.33%-1.98B
-295.46%-680.6M
182.95%327.4M
39.71%-16.7M
99.70%-1.1M
Cash from discontinued investing activities
Investing cash flow
89.47%-241.4M
-213.35%-2.3B
-19,601.13%-6.95B
-1,573.98%-2.7B
-1,379.23%-1.23B
-2,823.21%-2.29B
-355.88%-735.4M
93.76%-35.3M
-61.16%-161M
79.59%-83.3M
Financing cash flow
Cash flow from continuing financing activities
85.99%-22.9M
97.32%-7.8M
45.14%-778.6M
80.06%-12.9M
52.40%-311M
79.09%-163.4M
-462.76%-291.3M
-1,606.69%-1.42B
-32.31%-64.7M
-12,228.30%-653.4M
Net issuance payments of debt
-143.62%-22.9M
16.13%-7.8M
32.15%-40.1M
-34.44%-12.1M
3.13%-9.3M
8.74%-9.4M
69.21%-9.3M
11.39%-59.1M
81.60%-9M
-81.13%-9.6M
Net common stock issuance
--0
--0
15.69%-738.5M
98.56%-800K
53.14%-301.7M
46.32%-154M
-355.20%-282M
-644.38%-875.9M
---55.7M
---643.8M
Cash dividends paid
----
----
--0
--0
--0
----
----
---484.3M
--0
--0
Cash from discontinued financing activities
Financing cash flow
85.99%-22.9M
97.32%-7.8M
45.14%-778.6M
80.06%-12.9M
52.40%-311M
79.09%-163.4M
-462.76%-291.3M
-1,606.69%-1.42B
-32.31%-64.7M
-12,228.30%-653.4M
Net cash flow
Beginning cash position
-26.08%8.98B
-15.94%11.66B
719.70%13.88B
0.54%13.5B
51.76%14.17B
97.01%12.14B
719.70%13.88B
39.87%1.69B
562.67%13.42B
921.20%9.33B
Current changes in cash
-29.44%1.36B
-54.30%-2.63B
-119.48%-2.36B
-407.72%-1.86B
-118.11%-732M
-36.86%1.93B
-138.57%-1.7B
2,801.58%12.12B
273.27%603.5M
271.73%4.04B
Effect of exchange rate changes
-59.21%37.2M
-112.55%-57.6M
152.18%150.3M
116.44%25M
31.05%61.2M
-18.21%91.2M
-150.65%-27.1M
-7.88%59.6M
-1,094.12%-152.1M
92.98%46.7M
End cash Position
-26.75%10.38B
-26.08%8.98B
-15.94%11.66B
-15.94%11.66B
0.54%13.5B
51.76%14.17B
97.01%12.14B
719.70%13.88B
719.70%13.88B
562.67%13.42B
Free cash flow
-63.56%1.49B
37.97%-454.2M
-64.69%4.67B
-3.51%660.7M
-85.95%660M
6.08%4.08B
-118.35%-732.2M
1,696.13%13.21B
370.74%684.7M
221.77%4.7B
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -62.91%1.63B53.16%-317.3M-60.44%5.37B2.62%850.9M-83.03%811.2M11.93%4.39B-116.73%-677.4M1,426.06%13.58B515.64%829.2M218.42%4.78B
Net income from continuing operations -95.49%-805.8M-146.88%-331.8M-90.84%1.19B-79.10%663.2M-90.70%227.4M-117.77%-412.2M-85.90%707.7M-13.91%12.95B-32.70%3.17B-47.63%2.44B
Operating gains losses 96.92%-8.4M-120.85%-27M-130.82%-118.7M-70.02%157.3M-118.05%-20.6M-5.82%-272.9M2,983.33%129.5M218.27%385.1M1,047.11%524.7M167.40%114.1M
Depreciation and amortization 56.43%49.9M21.97%38.3M48.74%183.4M171.72%78.8M23.28%41.3M-3.92%31.9M13.77%31.4M63.96%123.3M11.54%29M69.19%33.5M
Other non cash items 10.60%-140M78.70%-172.5M-328.16%-1.28B-89.70%-158.4M-2,854.90%-150.7M-7,557.14%-156.6M-281.26%-809.8M-249.62%-297.9M-1,310.14%-83.5M-108.32%-5.1M
Change In working capital -49.72%2.37B366.46%222.5M23.38%5.57B45.18%-803.8M-77.83%639.4M80.73%4.7B-90.41%47.7M142.11%4.52B-0.45%-1.47B193.07%2.88B
-Change in receivables -61.33%1.6B-44.26%498.2M22.98%5.37B-97.06%-1.27B-71.89%631.2M30.31%4.14B321.51%893.8M137.01%4.37B62.24%-646.8M167.15%2.25B
-Change in inventory 121.37%5.3M-20.65%12.3M30.21%81.9M140.06%58M-54.46%33.2M-127.07%-24.8M-64.12%15.5M114.35%62.9M-32.72%-144.8M182.84%72.9M
-Change in payables and accrued expense 28.36%760.8M66.57%-288M38.74%118.9M161.19%412.8M-104.42%-25M189.38%592.7M-200.48%-861.6M-94.35%85.7M-286.25%-674.6M69.99%565.9M
Cash from discontinued investing activities
Operating cash flow -62.91%1.63B53.16%-317.3M-60.44%5.37B2.62%850.9M-83.03%811.2M11.93%4.39B-116.73%-677.4M1,426.06%13.58B515.64%829.2M218.42%4.78B
Investing cash flow
Cash flow from continuing investing activities 89.47%-241.4M-213.35%-2.3B-19,601.13%-6.95B-1,573.98%-2.7B-1,379.23%-1.23B-2,823.21%-2.29B-355.88%-735.4M93.76%-35.3M-61.16%-161M79.59%-83.3M
Net PPE purchase and sale -31.55%-88.4M-29.42%-58.5M23.89%-250.1M38.64%-83.7M30.32%-54M4.82%-67.2M-2.49%-45.2M-164.79%-328.6M-264.71%-136.4M-92.31%-77.5M
Net intangibles purchase and sale 78.23%-52.7M-716.67%-78.4M-1,235.48%-455.4M-1,248.10%-106.5M-1,968.09%-97.2M-4,943.75%-242.1M42.51%-9.6M-28.68%-34.1M43.57%-7.9M-487.50%-4.7M
Net business purchase and sale -----------336.9M--0---336.9M----------0--0--0
Net investment purchase and sale 94.94%-100.3M-218.47%-2.17B-1,905.77%-5.91B-14,899.40%-2.5B-67,545.45%-744.1M-65,983.33%-1.98B-295.46%-680.6M182.95%327.4M39.71%-16.7M99.70%-1.1M
Cash from discontinued investing activities
Investing cash flow 89.47%-241.4M-213.35%-2.3B-19,601.13%-6.95B-1,573.98%-2.7B-1,379.23%-1.23B-2,823.21%-2.29B-355.88%-735.4M93.76%-35.3M-61.16%-161M79.59%-83.3M
Financing cash flow
Cash flow from continuing financing activities 85.99%-22.9M97.32%-7.8M45.14%-778.6M80.06%-12.9M52.40%-311M79.09%-163.4M-462.76%-291.3M-1,606.69%-1.42B-32.31%-64.7M-12,228.30%-653.4M
Net issuance payments of debt -143.62%-22.9M16.13%-7.8M32.15%-40.1M-34.44%-12.1M3.13%-9.3M8.74%-9.4M69.21%-9.3M11.39%-59.1M81.60%-9M-81.13%-9.6M
Net common stock issuance --0--015.69%-738.5M98.56%-800K53.14%-301.7M46.32%-154M-355.20%-282M-644.38%-875.9M---55.7M---643.8M
Cash dividends paid ----------0--0--0-----------484.3M--0--0
Cash from discontinued financing activities
Financing cash flow 85.99%-22.9M97.32%-7.8M45.14%-778.6M80.06%-12.9M52.40%-311M79.09%-163.4M-462.76%-291.3M-1,606.69%-1.42B-32.31%-64.7M-12,228.30%-653.4M
Net cash flow
Beginning cash position -26.08%8.98B-15.94%11.66B719.70%13.88B0.54%13.5B51.76%14.17B97.01%12.14B719.70%13.88B39.87%1.69B562.67%13.42B921.20%9.33B
Current changes in cash -29.44%1.36B-54.30%-2.63B-119.48%-2.36B-407.72%-1.86B-118.11%-732M-36.86%1.93B-138.57%-1.7B2,801.58%12.12B273.27%603.5M271.73%4.04B
Effect of exchange rate changes -59.21%37.2M-112.55%-57.6M152.18%150.3M116.44%25M31.05%61.2M-18.21%91.2M-150.65%-27.1M-7.88%59.6M-1,094.12%-152.1M92.98%46.7M
End cash Position -26.75%10.38B-26.08%8.98B-15.94%11.66B-15.94%11.66B0.54%13.5B51.76%14.17B97.01%12.14B719.70%13.88B719.70%13.88B562.67%13.42B
Free cash flow -63.56%1.49B37.97%-454.2M-64.69%4.67B-3.51%660.7M-85.95%660M6.08%4.08B-118.35%-732.2M1,696.13%13.21B370.74%684.7M221.77%4.7B
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Infectious Disease
Infectious Disease
Intraday+0.80%